hydroxyurea has been researched along with Arthus Phenomenon in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Plasma level of intact SC-57461 (3 h after oral gavage dosing with 3 mg/kg) was 0." | 1.31 | Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies. ( Askonas, LJ; Ghoreishi-Haack, N; Kachur, JF; Liang, CD; Russell, MA; Smith, WG; Villani-Price, D; Won-Kim, S, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kachur, JF | 1 |
| Askonas, LJ | 1 |
| Villani-Price, D | 1 |
| Ghoreishi-Haack, N | 1 |
| Won-Kim, S | 1 |
| Liang, CD | 1 |
| Russell, MA | 1 |
| Smith, WG | 1 |
1 other study available for hydroxyurea and Arthus Phenomenon
| Article | Year |
|---|---|
Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
Topics: Administration, Oral; Administration, Topical; Animals; Arthus Reaction; beta-Alanine; Dermatitis; E | 2002 |